Moxifloxacin Ophthalmic

282 interactions 387 cited references

Also sold as: Moxeza® Vigamox Vigamox®

About Moxifloxacin Ophthalmic

Moxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 251 Major 19 Moderate

All (282) Contraindicated (12) Major (251) Moderate (19)

Major

Moxifloxacin Ophthalmic Protriptyline Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Quetiapine Seroquel An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Quinidine Cardioquin® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Quinine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Quizartinib Vanflyta An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ranolazine Aspruzyo Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Rasagiline Azilect Increased rasagiline exposure Details Moxifloxacin Ophthalmic Relugolix Orgovyx Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Repaglinide Prandin® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Revumenib Revuforj An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ribociclib Kisqali An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Rifampin Rifadin Reduced moxifloxacin exposure Details Moxifloxacin Ophthalmic Rilpivirine Edurant Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Risperidone Perseris Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ritonavir Norvir Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Rosiglitazone Avandia® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Saxagliptin Onglyza Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Selpercatinib Retevmo Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Semaglutide Ozempic Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Sertindole Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sertraline An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sevoflurane Petrem Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Siponimod Mayzent An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sitagliptin Brynovin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Sodium Phosphate OsmoPrep Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sodium Phosphate, Dibasic Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sodium Phosphate, Monobasic Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Solifenacin Vesicare Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sorafenib Nexavar Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sotalol Betapace Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sulpiride An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Sunitinib Sutent Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Tacrolimus Astagraf Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Taletrectinib Ibtrozi Increased risk of QT interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Tamoxifen Nolvadex® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Telaprevir Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Telavancin Vibativ Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Telithromycin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Tetrabenazine Xenazine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Tolazamide Tolinase® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.